Calreticulin surface exposure is abrogated in cells lacking, chaperone-mediated autophagy-essential gene, LAMP2A

Dear Editor,

Surface-exposed calreticulin (ecto-CRT) and secreted ATP have emerged as incontrovertible danger signals.^{1, 2, 3} A surge in studies describing the impact of these danger signals has also spurred a tremendous interest in the discovery of signaling pathways regulating their ‘emission'. Recent research has shown that the pathways regulating the emission of these danger signals exhibit a certain degree of ‘plasticity' and context-dependency.^{1, 2, 3, 4} This applies mainly to the pathways regulating ecto-CRT emission and ATP secretion induced by mitoxantrone (MTX)² and hypericin-based photodynamic therapy (Hyp-PDT).^{3, 4, 5}

Irrespective of the inducers though, molecular components regulating endoplasmic reticulum (ER)-stress and autophagy have been found to form the ‘core' of pathways behind ecto-CRT and secreted ATP.^{1, 3, 5} While ER-stress tends to regulate these pathways positively,^{1, 3} macroautophagy has recently emerged to play a more contextual role.^{1, 6} While on one hand, macroautophagy was found to positively regulate MTX-induced ATP secretion,² on the other we found that macroautophagy negatively regulates Hyp-PDT-induced ecto-CRT⁶ (without affecting ATP secretion⁶). This further increased our curiosity regarding the role of autophagy pathways behind ecto-CRT/secreted ATP. Interestingly, it was recently shown that the lysosomal protein LAMP1 can regulate MTX-induced ATP secretion.² We have previously shown that oxidative stress generated by Hyp-PDT along with macroautophagy can stimulate chaperone-mediated autophagy (CMA), a process mediated by the lysosomal protein, LAMP2A^{7, 8} Cells lacking LAMP2A were found to be extremely sensitized toward Hyp-PDT-induced apoptotic cell death, which is mediated by severe reactive oxygen species-induced ER stress.⁷ On the back of these exciting results, we became curious about the impact this CMA-essential gene can have on cell-surface exposure of CRT and secretion of ATP.

To this end, we tested the ability of LAMP2A^+/+ and LAMP2A^−/− cells to emit secreted ATP/ecto-CRT following MTX/Hyp-PDT treatments. MTX and Hyp-PDT induced significant secretion of ATP in LAMP2A^+/+ cells as compared with the untreated cells (Supplementary Figure S1A). Similarly, the LAMP2A^−/− cells also retained their capacity to secrete ATP following MTX/Hyp-PDT treatment, to the same extent as the LAMP2A^+/+ cells (Supplementary Figure S1A).

Next, we analyzed the induction of ecto-CRT and found both MTX and Hyp-PDT to be potent inducers of ecto-CRT in the LAMP2A^+/+ cells (Supplementary Figure S1B), as expected.^{4, 5} Interestingly, we found that the LAMP2A^−/− cells exhibited a strong inability to emit ecto-CRT, not only following MTX/Hyp-PDT treatments but also in basal conditions (Supplementary Figure S1B). This complete abrogation of ecto-CRT in the absence of LAMP2A indicated an ‘innate' dysfunction of ecto-CRT trafficking pathway in these cells. It has been well established that cells lacking LAMP2A exhibit a compensatory rise in macroautophagy, under basal conditions, to counter the absence of CMA.^{7, 8} We had recently observed that ablation of macroautophagy (via ATG5-siRNA) increased Hyp-PDT-induced ecto-CRT.⁶ Thus, we wondered whether we can rescue ecto-CRT emission in LAMP2A^−/− cells if we knockdown ATG5 (ATG5^KD). ATG5^KD in LAMP2A^+/+ cells (Supplementary Figure S1C, left) further increased the induction of ecto-CRT after treatment (as compared with LAMP2A^+/+ cells transfected with Scr-siRNA) (Supplementary Figure S1C, right), especially after Hyp-PDT, as expected.⁶ Contrary to expectations though, ATG5^KD in LAMP2A^−/− cells (∼50%^KD; Supplementary Figure S1C, left) failed to re-establish ecto-CRT, both under basal and treated conditions (Supplementary Figure S1C, right). These results indicate that possibly the absence of CMA in LAMP2A^−/− cells underlies their inability to emit ecto-CRT (rather than compensatory rise in ATG5-regulated macroautophagy) – a premise that needs to be comprehensively investigated.

In conclusion, we found that LAMP2A is dispensable for both MTX and Hyp-PDT-induced ATP secretion. However interestingly, we observed that the absence of LAMP2A abrogates ecto-CRT emission (in basal and MTX/Hyp-PDT treatment scenarios) – a dysfunction that cannot be rescued by siRNA-based knock-down of ATG5. In future, it would be imperative to investigate whether there is a direct link between ecto-CRT emission and CMA induction.

The authors declare no conflict of interest.